Cancer · US
Cancer · US · 11 stories in 12h · Clear all filters
-
Bloomberg
Sellas Life Sciences Stock Triples After Cancer Vaccine DataSellas Life Sciences Group Inc. surged after the drug developer reported positive late-stage trial results for an experimental…
-
My family history of cancer was giving me so much anxiety. I finally learned to stop turning to Dr. Google.Every medical test triggered my fear of cancer, and searching my symptoms online made it worse. I had…
- Nasdaq.com Axe Compute Inc. Reports Third Quarter 2026 Financial ResultsPredictive Oncology Inc. (operating as Axe Compute Inc.) reported its financial results for the third quarter ended September…
- Seeking Alpha Lilly inks oncology licensing deal worth up to $5.9B with Stipple Bio
- Nasdaq.com bioAffinity Technologies, Inc. Reports Record Monthly Testing Volume in October 2026 for CyPath LungbioAffinity Technologies, Inc. announced that a record number of CyPath® Lung tests were performed in October 2026, marking…
-
Alphabet's Isomorphic Labs Raises $5 Billion In Sequoia-Led Funding RoundThe company says it's now near preclinical studies for its first oncology program.
- Nasdaq.com Adagene and City of Hope Open Clinical Trial to Test New Therapy for Patients with Hard-to-Treat Colorectal CancerAdagene Inc. and City of Hope have announced the launch of an investigator-initiated Phase 1 clinical trial to…
-
SELLAS Life Sciences stock soars 240% on positive cancer trial
-
I founded a cancer biotech company. Then, my mom, dad, and I were all diagnosed with cancer.Dr. Ryan Beal is the CEO of Dyve, a cancer-biotech company. He, his dad, and his mom have…
-
Pancreatic cancer mystery deepens as researchers make unexpected discoveryUniversity of Cincinnati study found Black patients' pancreatic tumors had more B cells and cells tied to drug…
-
BeOne Medicines at Jefferies: oncology shift broadens beyond BRUKINSA
1 more story in other languages (French 1) ·